Transient cyclic neutropenia following GM-CSF in a patient with chronic granulocytic leukemia transplanted with HLA-identical T cell-depleted donor bone marrow

Bone Marrow Transplant. 1989 Sep;4(5):591-2.

Abstract

Treatment with GM-CSF or G-CSF is becoming widely used in patients with chronic neutropenia, or who are aplastic following chemotherapy or autologous or allogeneic bone marrow transplantation. Recently, some authors have described a phenomenon analogous to cyclic agranulocytosis following treatment with G-CSF in a patient with chronic neutropenia. We wish to describe the same phenomenon in a patient with chronic granulocytic leukemia who received GM-CSF (Sandoz) after T cell depletion in order to accelerate hematological reconstitution.

Publication types

  • Case Reports

MeSH terms

  • Agranulocytosis / etiology*
  • Bone Marrow / pathology
  • Bone Marrow Transplantation* / pathology
  • Colony-Stimulating Factors / adverse effects*
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Growth Substances / adverse effects*
  • HLA Antigens
  • Humans
  • Leukemia, Myeloid, Chronic-Phase / immunology
  • Leukemia, Myeloid, Chronic-Phase / surgery*
  • Leukemia, Myeloid, Chronic-Phase / therapy
  • Leukocyte Count
  • Lymphocyte Depletion
  • Middle Aged
  • Neutropenia / blood
  • Neutropenia / etiology*
  • Neutropenia / pathology
  • Periodicity
  • T-Lymphocytes

Substances

  • Colony-Stimulating Factors
  • Growth Substances
  • HLA Antigens
  • Granulocyte-Macrophage Colony-Stimulating Factor